Dr. Todd Henderson, MD

NPI: 1710163050
Total Payments
$7,112
2024 Payments
$933.07
Companies
40
Transactions
371
Medicare Patients
7,345
Medicare Billing
$764,468

Payment Breakdown by Category

Food & Beverage$6,935 (97.5%)
Education$177.25 (2.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,935 364 97.5%
Education $177.25 7 2.5%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $1,024 63 $0 (2024)
Actelion Pharmaceuticals US, Inc. $775.92 46 $0 (2022)
AstraZeneca Pharmaceuticals LP $647.13 31 $0 (2024)
Genentech USA, Inc. $608.59 27 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $542.16 22 $0 (2024)
Insmed, Inc. $404.08 16 $0 (2024)
Sunovion Pharmaceuticals Inc. $400.13 30 $0 (2019)
Bayer Healthcare Pharmaceuticals Inc. $238.62 15 $0 (2023)
Grifols USA, LLC $225.59 17 $0 (2022)
GENZYME CORPORATION $222.90 7 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $933.07 33 GlaxoSmithKline, LLC. ($177.89)
2023 $927.35 46 GlaxoSmithKline, LLC. ($191.21)
2022 $578.32 29 GlaxoSmithKline, LLC. ($277.66)
2021 $398.18 21 Actelion Pharmaceuticals US, Inc. ($238.96)
2020 $581.80 26 Insmed, Inc. ($247.53)
2019 $1,208 62 Genentech USA, Inc. ($272.27)
2018 $1,261 71 Genentech USA, Inc. ($221.80)
2017 $1,224 83 Sunovion Pharmaceuticals Inc. ($214.28)

All Payment Transactions

371 individual payment records from CMS Open Payments — Page 1 of 15

Date Company Product Nature Form Amount Type
12/26/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $17.52 General
Category: RESPIRATORY
12/11/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $24.98 General
Category: INFLAMMATION AND IMMUNOLOGY
12/10/2024 AstraZeneca Pharmaceuticals LP TEZSPIRE (Biological) Food and Beverage In-kind items and services $21.11 General
Category: Respiratory
11/19/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $13.85 General
Category: RESPIRATORY
11/14/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $18.24 General
Category: RESPIRATORY
10/17/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $18.31 General
Category: IMMUNOLOGY
10/03/2024 AstraZeneca Pharmaceuticals LP TEZSPIRE (Biological) Food and Beverage In-kind items and services $20.77 General
Category: Respiratory
10/03/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $15.52 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
10/01/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $15.00 General
Category: RESPIRATORY
09/19/2024 HARMONY BIOSCIENCES LLC WAKIX (Drug) Food and Beverage Cash or cash equivalent $31.91 General
Category: Narcoplepsy
09/17/2024 Merck Sharp & Dohme LLC WINREVAIR (Biological) Food and Beverage In-kind items and services $112.84 General
Category: CARDIOVASCULAR
09/12/2024 AstraZeneca Pharmaceuticals LP TEZSPIRE (Biological) Food and Beverage In-kind items and services $19.97 General
Category: Respiratory
09/11/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $19.94 General
Category: RESPIRATORY
09/05/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $17.37 General
Category: IMMUNOLOGY
09/04/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $15.51 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
08/24/2024 JAZZ PHARMACEUTICALS INC. XYWAV (Drug) Food and Beverage In-kind items and services $39.63 General
Category: NEUROLOGY
08/22/2024 HARMONY BIOSCIENCES LLC WAKIX (Drug) Food and Beverage Cash or cash equivalent $37.15 General
Category: Narcoplepsy
08/15/2024 Merck Sharp & Dohme LLC WINREVAIR (Biological) Food and Beverage In-kind items and services $9.85 General
Category: CARDIOVASCULAR
08/14/2024 ZOLL Respicardia, Inc. remede System (Device) Food and Beverage Cash or cash equivalent $120.72 General
Category: Respiratory
08/14/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $18.35 General
Category: IMMUNOLOGY
07/30/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $13.60 General
Category: RESPIRATORY
07/18/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $16.45 General
Category: IMMUNOLOGY
07/17/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $20.03 General
Category: Respiratory
07/01/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $26.95 General
Category: INFLAMMATION AND IMMUNOLOGY
06/26/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $12.26 General
Category: RESPIRATORY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 27 1,787 2,196 $428,905 $161,204
2022 26 1,762 2,301 $467,065 $170,375
2021 26 1,921 2,641 $560,431 $206,371
2020 25 1,875 2,700 $605,168 $226,517
Total Patients
7,345
Total Services
9,838
Medicare Billing
$764,468
Procedure Codes
110

All Medicare Procedures & Services

110 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 319 408 $81,600 $35,881 44.0%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 138 297 $56,430 $26,519 47.0%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 161 164 $57,400 $21,195 36.9%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 173 265 $34,450 $15,809 45.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 235 259 $34,965 $15,350 43.9%
99291 Critical care, first 30-74 minutes Facility 2023 50 75 $30,375 $11,966 39.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 64 64 $19,520 $7,457 38.2%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 19 19 $5,244 $5,139 98.0%
94375 Test to measure rate of airflow Office 2023 138 145 $14,500 $3,643 25.1%
95811 Sleep study in sleep lab with continuous airway pressure (6 years or older) Facility 2023 26 29 $17,400 $2,636 15.2%
94729 Test to examine how well the lungs exchange gases Office 2023 58 62 $8,680 $2,404 27.7%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 24 24 $5,760 $2,090 36.3%
95810 Sleep study in sleep lab (6 years or older) Facility 2023 22 22 $13,200 $1,967 14.9%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 24 24 $4,800 $1,829 38.1%
31500 Emergent insertion of breathing tube into windpipe using an endoscope Facility 2023 14 14 $6,300 $1,476 23.4%
31624 Irrigation and suction of lung airways to obtain cells using an endoscope Facility 2023 15 15 $7,500 $806.59 10.8%
36556 Insertion of non-tunneled central venous tube for infusion (5 years or older) Facility 2023 11 12 $5,400 $718.87 13.3%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Office 2023 23 23 $3,335 $624.91 18.7%
G0009 Administration of pneumococcal vaccine Office 2023 21 21 $630.00 $589.05 93.5%
71046 X-ray of chest, 2 views Office 2023 23 23 $2,645 $502.95 19.0%
94727 Test to determine lung volumes using gas dilution or washout Office 2023 16 16 $1,840 $492.16 26.7%
G0008 Administration of influenza virus vaccine Office 2023 16 16 $480.00 $448.80 93.5%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Facility 2023 49 49 $6,987 $363.21 5.2%
94726 Test to determine lung volumes using sensors Facility 2023 40 40 $3,058 $343.40 11.2%
94729 Test to examine how well the lungs exchange gases Facility 2023 49 49 $5,001 $313.54 6.3%

About Dr. Todd Henderson, MD

Dr. Todd Henderson, MD is a Critical Care Medicine healthcare provider based in Southaven, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1710163050.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Todd Henderson, MD has received a total of $7,112 in payments from pharmaceutical and medical device companies, with $933.07 received in 2024. These payments were reported across 371 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($6,935).

As a Medicare-enrolled provider, Henderson has provided services to 7,345 Medicare beneficiaries, totaling 9,838 services with total Medicare billing of $764,468. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.

Practice Information

  • Specialty Critical Care Medicine
  • Other Specialties Critical Care Medicine, Pulmonary Disease
  • Location Southaven, MS
  • Active Since 01/16/2008
  • Last Updated 03/28/2023
  • Taxonomy Code 207RC0200X
  • Entity Type Individual
  • NPI Number 1710163050

Products in Payments

  • TRELEGY ELLIPTA (Drug) $492.12
  • UPTRAVI (Drug) $400.67
  • Arikayce (Drug) $366.16
  • NUCALA (Biological) $364.37
  • OFEV (Drug) $289.56
  • Xolair (Biological) $277.28
  • Adempas (Drug) $238.62
  • UTIBRON (Drug) $195.18
  • WAKIX (Drug) $194.88
  • OPSUMIT MACITENTAN (Drug) $184.75
  • FASENRA (Drug) $172.53
  • Utibron (Drug) $162.01
  • BREZTRI (Drug) $152.87
  • OPSUMIT (Drug) $147.07
  • DUPIXENT (Drug) $142.63
  • remede System (Device) $140.80
  • DUPIXENT (Biological) $132.20
  • TEZSPIRE (Biological) $127.73
  • WINREVAIR (Biological) $122.69
  • Prolastin-C Liquid (Biological) $121.23

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Critical Care Medicine Doctors in Southaven